An at-home sleep apnea test will be available to Ontario patients for the first time as the result of a unique MaRS program.
BresoDx, a portable test for sleep apnea, is the first technology to complete MaRS EXCITE, an innovative initiative that accelerates the adoption of health technology in Ontario.
The breakthrough medical device, developed by BresoTec, will be rolled out to select clinics in the province. BresoDx offers a patient-centred option for sleep testing. Patients can use the device at home rather than in a sleep laboratory.
"Giving patients in Ontario the ability to test for sleep apnea in the comfort of their own home represents a key validation for BresoTec as we look to bring our technology to international markets," says Dr. Geoff Fernie, CEO of BresoTec and Director, Research Institute, Toronto Rehab.
Through MaRS EXCITE, the Ontario-based company was able to collaborate with the Ontario Ministry of Health and Long-Term Care (MOHLTC) and other key stakeholders to gather the appropriate evidence and develop an implementation plan, key factors required for adoption within any health system.
Here are the full details of the announcement about BresoDx.
